BuybackMay 28, 2026, 09:17 AM
Fresenius Medical Care launches EUR 1B share buyback program
AI Summary
Fresenius Medical Care AG announced the launch of a new share buyback program totaling up to EUR 1 billion. The program commenced on May 28, 2026, and is expected to conclude by May 27, 2027. The first tranche, valued at up to EUR 600 million, is scheduled to be completed by December 15, 2026. The repurchased shares will primarily be cancelled to reduce share capital, with a smaller portion allocated to incentive-based compensation plans.
Key Highlights
- Fresenius Medical Care launches a new share buyback program of up to EUR 1 billion.
- The first tranche is for up to EUR 600 million, expected to complete by December 15, 2026.
- The overall program runs from May 28, 2026, to May 27, 2027.
- Up to 29,341,344 shares (ISIN DE0005785802) may be repurchased.
- Repurchased shares are primarily for cancellation and share capital reduction.
- The program is based on authorization from the General Meeting on May 21, 2026.
- Buyback will comply with safe-harbor provisions of EU Regulation No 596/2014.
Price Impact
More from FMS